Skip to main content

Table 1 Clinical characteristics of patients

From: Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans

CHS

Age (YEARS)

M/F

CS (%)

TC

TG

HDL

LDL

SBP

DBP

DM

HT (%)

HL (%)

P

Stroke (24 h)

             

LA (n = 10)

62 ± 7

5/5

2 (20%)

4.48 ± 0.71

1.53 ± 0.43

1.13 ± 0.18

2.53 ± 0.58

132 ± 12

84 ± 13

1 (10%)

2 (20%)

2 (20%)

0.12

SA (n = 9)

63 ± 6

4/5

2 (22%)

4.32 ± 0.63

1.43 ± 0.23

1.24 ± 0.16

2.42 ± 0.61

125 ± 10

82 ± 14

2 (22%)

2 (22%)

1 (11%)

0.32

CEmb (n = 9)

64 ± 5

5/4

1 (11%)

4.18 ± 0.52

1.23 ± 0.18

1.02 ± 0.12

2.43 ± 0.47

130 ± 12

85 ± 11

1 (11%)

1 (11%)

1 (11%)

0.46

UDN (n = 10)

61 ± 6

5/5

2 (20%)

4.23 ± 0.34

1.36 ± 0.33

1.25 ± 0.27

2.45 ± 0.45

135 ± 13

80 ± 13

1 (10%)

2 (20%)

2 (20%)

0.78

Stroke (1 W)

             

LA (n = 11)

65 ± 6

5/6

2 (18%)

4.12 ± 0.25

1.54 ± 0.46

1.15 ± 0.12

2.50 ± 0.35

128 ± 14

82 ± 10

1 (9%)

2 (18%)

2 (20%)

0.98

SA (n = 10)

66 ± 4

5/5

2 (20%)

4.16 ± 0.32

1.44 ± 0.35

1.10 ± 0.17

2.43 ± 0.42

138 ± 27

86 ± 14

1 (10%)

2 (20%)

1 (10%)

0.54

CEmb (n = 11)

62 ± 7

6/5

2 (18%)

4.31 ± 0.17

1.32 ± 0.38

1.15 ± 0.14

2.46 ± 0.38

137 ± 10

85 ± 13

1 (9%)

1 (9%)

1 (9%)

0.65

UDN (n = 10)

63 ± 7

4/6

2 (20%)

4.42 ± 0.54

1.42 ± 0.43

1.17 ± 0.12

2.35 ± 0.36

132 ± 15

87 ± 11

1 (10%)

1 (10%)

1 (10%)

0.98

Stroke (4 W)

             

LA (n = 10)

65 ± 5

6/4

2 (20%)

4.39 ± 0.47

1.55 ± 0.39

1.18 ± 0.13

2.62 ± 0.56

130 ± 12

88 ± 10

1 (10%)

2 (20%)

2 (20%)

0.82

SA (n = 10)

64 ± 7

4/6

1 (10%)

4.36 ± 0.52

1.36 ± 0.36

1.09 ± 0.13

2.43 ± 0.34

129 ± 16

85 ± 11

2 (20%)

2 (20%)

1 (10%)

0.12

CEmb (n = 10)

63 ± 7

5/5

2 (20%)

4.26 ± 0.17

1.38 ± 0.29

1.12 ± 0.17

2.43 ± 0.33

130 ± 12

86 ± 10

1 (10%)

1 (10%)

1 (10%)

0.12

UDN (n = 10)

64 ± 6

6/4

2 (20%)

4.24 ± 0.43

1.42 ± 0.35

1.19 ± 0.16

2.44 ± 0.44

127 ± 13

82 ± 12

1 (10%)

2 (20%)

1 (10%)

0.34

Stroke (24 W)

             

LA (n = 10)

65 ± 7

6/4

1 (10%)

4.36 ± 0.27

1.56 ± 0.42

1.14 ± 0.15

2.43 ± 0.56

126 ± 15

88 ± 12

1 (10%)

2 (20%)

2 (20%)

0.87

SA (n = 9)

66 ± 6

4/5

1 (11%)

4.39 ± 0.59

1.44 ± 0.32

1.17 ± 0.12

2.39 ± 0.45

124 ± 13

83 ± 11

2 (22%)

2 (22%)

1 (11%)

0.23

CEmb (n = 10)

64 ± 5

5/5

1 (10%)

4.35 ± 0.49

1.37 ± 0.41

1.15 ± 0.16

2.50 ± 0.43

126 ± 15

85 ± 12

1 (10%)

1 (10%)

1 (10%)

0.13

UDN (n = 9)

65 ± 6

5/4

1 (11%)

429 ± 0.39

1.49 ± 0.29

1.19 ± 0.18

2.45 ± 0.45

125 ± 13

86 ± 11

1 (11%)

1 (11%)

1 (11%)

0.56

Stroke (48 W)

             

LA (n = 10)

64 ± 7

6/4

2 (20%)

4.46 ± 0.28

1.57 ± 0.42

1.15 ± 0.13

2.55 ± 0.43

127 ± 12

84 ± 12

1 (10%)

2 (20%)

2 (20%)

0.11

SA (n = 10)

66 ± 5

5/5

2 (20%)

4.35 ± 0.42

1.43 ± 0.32

1.17 ± 0.20

2.46 ± 0.53

123 ± 11

83 ± 10

2 (20%)

1 (10%)

1 (10%)

0.45

CEmb (n = 10)

65 ± 7

4/6

1 (10%)

4.37 ± 0.42

1.38 ± 0.41

1.23 ± 0.15

2.61 ± 0.53

125 ± 10

87 ± 14

1 (10%)

1 (10%)

1 (10%)

0.55

UDN (n = 9)

64 ± 8

5/4

1 (11%)

4.44 ± 0.32

1.42 ± 0.33

1.17 ± 0.18

2.65 ± 0.62

129 ± 13

87 ± 13

1 (11%)

1 (10%)

1 (10%)

0.87

Healthy outpatient (n = 50)

64 ± 6

24/26

10 (20%)

4.52 ± 0.48

1.39 ± 0.40

1.15 ± 0.14

2.50 ± 0.62

125 ± 11

82 ± 11

5 (10%)

5 (10%)

6 (12%)

 
  1. CHS, Characteristics; M/F, Male/female; CS, Current smoking; TC, total cholesterol (mmol/L); TG, total glyceride (mmol/L); HDL, high-density lipoprotein (mmol/L); LDL, low-densitlipoprotein (mmol/L); SBP, systolic blood pressure (mmHg); DBP, diastolic blood pressure (mmHg); DM, diabetes mellitus; HT, Hypertension; HL, Hyperlipidaemia; LA, Large artery stroke; SA, Small artery stroke; CEmb, Cardioembolic stroke; UDN, stroke due to undetermined cause; P, comparison between patients with healthy adult.